Catalog |
name |
Description |
price |
R-XASYS-00747 |
AZD 9272,cas:327056-26-8 |
AZD 9272(C14H6F2N4O,284.2) is a fluorinated heterocyclic compound, which is an important synthetic intermediate in organic chemistry. AZD 9272 has a wide range of applications in the fields of organic synthesis, pharmaceuticals, and materials science. |
price> |
R-XASYS-00748 |
AZD-5991,cas:2143061-81-6 |
AZD-5991(C35H34ClN5O3S2,672.26) is a potent and selective Mcl-1 inhibitor with an IC50 of 0.7 nM in FRET assay and a Kd of 0.17 nM in surface plasmon resonance (SPR) assay. |
price> |
R-XASYS-00749 |
AZD1152,cas:722543-31-9 |
AZD1152(C26H31FN7O6P,587.54), a pro-drug of Barasertib-hQPA, is a highly selective Aurora B inhibitor with an IC50 of 0.37 nM in a cell-free assay. Barasertib (AZD1152) induces growth arrest and apoptosis in cancer cells. |
price> |
R-XASYS-00750 |
AZD1283,cas:919351-41-0 |
AZD1283(C23H26N4O5S,470.54) is a potent P2Y12 receptor antagonist with a binding IC50 of 11 nM and a GTPγS IC50 of 25 nM. AZD1283 has excellent antiplatelet aggregation potency. AZD1283 can be used to research thromboembolic disorders. |
price> |
R-XASYS-00751 |
AZD-1656,cas:919783-22-5 |
AZD1656(C24H26N6O5,478.50) is a potent, selective and orally active glucokinase activator with an EC50 of 60 nM. AZD1656 has the potential for type 2 diabetes research |
price> |
R-XASYS-00752 |
AZD1979,cas:1254035-84-1 |
AZD1979(C25H26N4O5,462.50) is a Melanin-concentrating hormone receptor 1 (MCHr1) antagonist with an IC50 of ~12 nM. |
price> |
R-XASYS-00753 |
AZD3229 Tosylate,cas:2248003-71-4 |
AZD3229 Tosylate(C31H34FN7O6S,651.71) is a potent pan-KIT mutant inhibitor for the treatment of gastrointestinal stromal tumors. |
price> |
R-XASYS-00754 |
AZD3242,cas:890655-80-8 |
AZD3241(C11H15N3O2S,253.3) is a selective, irreversible and orally active myeloperoxidase (MPO) inhibitor, with an IC50 of 630 nM, and can be used in the research of neurodegenerative brain disorders. |
price> |
R-XASYS-00756 |
AZD4573,cas:2057509-72-3 |
AZD4573(C22H28ClN5O2,429.94) is a potent and highly selective CDK9 inhibitor (IC50 of <4 nM) that enables transient target engagement for the treatment of hematologic malignancies. |
price> |
R-XASYS-00757 |
AZD7507,cas:1041852-85-0 |
AZD7507(C23H27FN6O3,454.50) is a potent and orally active CSF-1R inhibitor, with antitumor activity. |
price> |